2010 Volume 25 Issue 6 Pages 552-564
A novel biomaterial of therapeutic oligonucleotides such as siRNA and miRNA exactly brought a new paradigm shift in the drug discovery. The technologies to overcome the off-target effects, enzymatic and membrane barrier for attaining a new medicine of these oligonucleotides are overviewed.